The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
某种意义上，Anthropic 提出的「蒸馏」争议，本身就是这个 AI 时代缩影。
，更多细节参见爱思助手下载最新版本
Владислав Уткин，更多细节参见爱思助手下载最新版本
Global news & analysis。服务器推荐对此有专业解读